C-reactive protein has appeared in more articles in this series than any other single marker. I've referenced it in the fatigue article, the heart health article, the gut health article, the athletes article, the brain fog article, the biohacking article, and the autoimmune article. Every time, I described it briefly as "a marker of systemic inflammation" and moved on.

It's time to give inflammation its own article.

Not because CRP is complicated. It's actually one of the simplest blood tests to understand. But because the concept it measures, systemic inflammation, is the thread that connects cardiovascular disease, metabolic syndrome, autoimmune conditions, gut dysfunction, neurological decline, cancer risk, and the process of ageing itself.

My own hs-CRP has been tested three times over the past two years. The first result was 2.1 mg/L, moderate cardiovascular risk zone. The second, after cleaning up my habits, was 0.8 mg/L. The third was 0.6 mg/L. That trajectory tells me more than any single reading. It confirms that lifestyle changes moved the inflammatory needle in the right direction.

A note before we get into it

What inflammation actually is

Everyone uses the fire analogy for inflammation. Your body detects a threat (infection, injury, tissue damage) and mounts an inflammatory response. White blood cells rush to the site. Blood vessels dilate to increase flow. Chemical messengers (cytokines, prostaglandins) coordinate the attack. Heat, redness, swelling, and pain signal that the battle is underway.

That's the part everyone describes. Here's the part they usually leave out: after the threat is eliminated, the fire is supposed to go out. Resolution of inflammation is an active process. Not just the absence of the trigger, but a coordinated anti-inflammatory response that clears debris, repairs tissue, and returns the system to baseline.

When the fire goes out properly, you heal. When it doesn't, when the inflammatory response smoulders at a low level indefinitely, that's chronic inflammation. And chronic inflammation doesn't produce the dramatic heat-redness-swelling-pain of an acute response. It produces something subtler: slow, sustained tissue damage that accumulates over years and manifests as cardiovascular disease, metabolic dysfunction, neurodegeneration, cancer, and accelerated ageing.

The difference between acute and chronic inflammation

Acute inflammation is protective. It's your immune system doing its job: responding to infection, clearing damaged tissue, initiating repair. It's visible (swelling, redness), symptomatic (pain, heat), measurable (CRP spikes dramatically), and self-limiting (resolves when the threat is eliminated). You want acute inflammation. It's how you survive infections and heal injuries.

Chronic low-grade inflammation is destructive. It's a sustained, low-level inflammatory state that persists without an obvious acute threat. It's invisible (no swelling or redness you can see), often asymptomatic (or produces vague symptoms like fatigue and brain fog), measurable only with sensitive tests (hs-CRP, not standard CRP), and self-perpetuating (the inflammatory state itself generates signals that maintain it).

The drivers of chronic inflammation

Visceral adiposity (belly fat produces inflammatory cytokines, essentially functioning as an endocrine organ), insulin resistance, poor diet (refined carbohydrates, seed oils, excessive sugar, ultra-processed foods), gut dysbiosis and intestinal permeability, chronic psychological stress, inadequate sleep, physical inactivity, excessive alcohol, smoking, environmental pollutants, and chronic infections.

Chronic low-grade inflammation is now understood as a central driver, not just a bystander, in the pathogenesis of atherosclerotic cardiovascular disease, type 2 diabetes, non-alcoholic fatty liver disease, Alzheimer's disease, certain cancers, and age-related functional decline. This understanding has reshaped cardiovascular risk assessment (hs-CRP is now part of the risk stratification conversation) and is influencing how we think about metabolic disease, neurodegeneration, and ageing itself.

CRP: your body's smoke detector

CRP (C-reactive protein) is produced by the liver in response to inflammatory signals (primarily interleukin-6) from anywhere in the body. When inflammation is present, CRP rises. When inflammation resolves, CRP falls. It's nonspecific. It doesn't tell you where the fire is, only that a fire exists.

Think of it like a smoke detector. If the alarm goes off, you know there's smoke somewhere in the house. It doesn't tell you which room, whether it's a kitchen mishap or a structural fire, or how serious the situation is. But it tells you something is happening that warrants investigation.

CRP kinetics: CRP rises within 6 to 8 hours of an inflammatory stimulus and can increase 1,000-fold during severe acute inflammation (sepsis, major tissue injury). It has a half-life of about 19 hours, meaning it drops relatively quickly once the inflammatory stimulus resolves. This makes CRP useful for monitoring the course of acute illness. A falling CRP suggests the situation is improving.

What CRP doesn't tell you: The cause of inflammation. An elevated CRP could reflect a bacterial infection, a viral illness, an autoimmune flare, a recent surgical procedure, active cancer, a gout attack, metabolic syndrome, or simply a bad week of sleep and stress. Clinical context determines what an elevated CRP means.

hs-CRP vs standard CRP

This is a distinction that confuses many people and is worth clarifying.

Standard CRP is calibrated to detect moderate-to-severe inflammation, the kind you see in acute infections, autoimmune flares, and major tissue injury. Its reference range typically extends from 0 to 10 mg/L, with values above 10 indicating significant inflammation. It's useful for monitoring acute illness but too blunt to detect the subtle, low-grade inflammation relevant to cardiovascular and metabolic risk.

hs-CRP (high-sensitivity CRP) measures the same protein using a more sensitive assay, capable of detecting much lower concentrations. This is the test designed to capture chronic low-grade inflammation in the 0 to 3 mg/L range that's relevant to cardiovascular risk stratification.

The cardiovascular risk categories (hs-CRP)

Below 1.0 mg/L: Lower cardiovascular risk.

1.0 to 3.0 mg/L: Moderate cardiovascular risk.

Above 3.0 mg/L: Higher cardiovascular risk (if not explained by acute illness, infection, or other obvious inflammatory cause).

For cardiovascular and metabolic risk assessment, hs-CRP is the appropriate test. Standard CRP is appropriate for monitoring acute illness, autoimmune disease activity, and post-surgical recovery. If you're ordering through Bloody Good for proactive health monitoring, hs-CRP is what you want.

ESR: the slow-moving companion marker

ESR (erythrocyte sedimentation rate) measures how quickly red blood cells settle to the bottom of a test tube over one hour. In the presence of inflammation, red blood cells clump together (due to elevated fibrinogen and immunoglobulins) and settle faster. Higher ESR means more inflammation.

ESR vs CRP: ESR rises more slowly than CRP (days rather than hours) and falls more slowly too. This makes it less useful for tracking acute changes but potentially more reflective of chronic inflammatory states. ESR is also influenced by non-inflammatory factors: anaemia, pregnancy, age, and sex all affect the sedimentation rate, which makes it less specific than CRP.

When ESR adds value alongside CRP: In autoimmune disease monitoring (rheumatoid arthritis, polymyalgia rheumatica, giant cell arteritis), ESR is often tracked alongside CRP because the two markers sometimes diverge. One may be elevated while the other is normal, providing complementary information about disease activity.

ESR availability: ESR is less commonly available through direct-to-consumer testing than CRP. If your GP is investigating a specific autoimmune or inflammatory condition, they may order ESR alongside CRP through the standard pathology pathway.

Other blood markers that signal inflammation

CRP and ESR are the headline inflammation markers, but several other tests on a standard blood panel provide inflammatory context.

White blood cell count (from FBC). Elevated neutrophils suggest bacterial infection or acute inflammation. Elevated lymphocytes suggest viral infection or chronic immune activation. Elevated eosinophils suggest allergy, parasitic infection, or eosinophilic conditions.

Platelet count (from FBC). Platelets are acute-phase reactants. They can be elevated during chronic inflammation (reactive thrombocytosis). This is a common incidental finding that sometimes prompts unnecessary worry.

Ferritin. Ferritin is both an iron storage marker and an acute-phase reactant. It rises during inflammation, which means a "normal" ferritin in someone with chronic inflammation may mask underlying iron deficiency. Conversely, a high ferritin doesn't always mean high iron stores. It may reflect inflammation rather than iron overload. See the iron article for this nuance.

Albumin. A negative acute-phase reactant. Albumin drops during chronic inflammation as the liver redirects protein synthesis toward inflammatory mediators. Low albumin with elevated CRP suggests a chronic inflammatory state affecting nutritional status.

Liver enzymes (ALT, GGT). Elevated in the context of metabolic inflammation (NAFLD, metabolic syndrome). These aren't classic "inflammatory markers" but they're often elevated alongside CRP in the chronic metabolic inflammation pattern. See the liver function article.

The chronic inflammation epidemic

The prevalence of chronic low-grade inflammation has been rising alongside obesity, metabolic syndrome, type 2 diabetes, and sedentary lifestyles. It's not a separate epidemic. It's the metabolic epidemic viewed through an inflammatory lens.

Visceral fat as an inflammatory organ. Abdominal fat tissue doesn't just store energy. It actively produces inflammatory cytokines (TNF-alpha, IL-6, MCP-1). The more visceral fat you carry, the more pro-inflammatory signalling your body generates. This is one of the primary mechanisms linking obesity to cardiovascular disease, diabetes, and cancer.

Insulin resistance and inflammation form a feedback loop. Inflammation promotes insulin resistance (by interfering with insulin signalling pathways). Insulin resistance promotes inflammation (through hyperglycaemia, oxidative stress, and metabolic dysfunction). Each drives the other, creating a self-perpetuating cycle that's difficult to break without addressing both simultaneously.

Gut health and systemic inflammation. Intestinal barrier dysfunction allows bacterial products (lipopolysaccharides) to cross from the gut into the bloodstream, triggering systemic immune activation. Gut dysbiosis, poor diet, alcohol, and chronic stress all contribute. See the gut health article.

Ultra-processed food. Emerging research links high ultra-processed food consumption to elevated inflammatory markers, through mechanisms involving gut microbiome disruption, advanced glycation end products (AGEs), and metabolic stress.

Sleep deprivation. Even short-term sleep restriction (fewer than 6 hours for several nights) elevates CRP and inflammatory cytokines. Chronic sleep deprivation sustains this elevation. See the sleep article.

Chronic psychological stress. Sustained cortisol activation shifts the immune system toward a pro-inflammatory state. The connection between stress and inflammation is well-established in psychoneuroimmunology research. See the cortisol article.

Inflammation and the conditions it connects to

A non-exhaustive list of conditions where chronic inflammation has a documented role, and where CRP or hs-CRP is used as part of risk assessment or monitoring.

Cardiovascular disease. Inflammation drives every stage of atherosclerosis, from initial endothelial damage to plaque development to plaque rupture (the event that triggers a heart attack). hs-CRP adds an inflammatory dimension to the standard lipid-based cardiovascular risk assessment. See the heart health article.

Metabolic syndrome and type 2 diabetes. Chronic inflammation is both a cause and a consequence of insulin resistance. CRP tracks alongside metabolic markers and improves risk prediction.

Non-alcoholic fatty liver disease. NAFLD is an inflammatory metabolic condition. CRP is often elevated alongside ALT and metabolic markers. See the liver function article.

Autoimmune conditions. CRP and ESR are used to monitor disease activity in rheumatoid arthritis, inflammatory bowel disease, lupus, and other autoimmune conditions. See the autoimmune article.

Neurodegenerative disease. Neuroinflammation is implicated in Alzheimer's disease, Parkinson's disease, and age-related cognitive decline. Systemic inflammation (measured by CRP) is associated with faster cognitive decline in epidemiological studies. See the brain fog article.

Cancer. Chronic inflammation creates a cellular environment that promotes DNA damage, proliferation, and immune evasion. CRP has been associated with increased risk of several cancers in population studies.

Ageing (inflammageing). The concept of "inflammageing," chronic low-grade inflammation as a driver of biological ageing, is one of the most active areas of gerontology research. hs-CRP is one of the markers used to characterise this phenomenon. See the biohacking article.

The anti-inflammatory lifestyle: what the evidence supports

This section is not about supplements or "anti-inflammatory protocols." It's about the lifestyle factors with the strongest evidence for reducing chronic inflammation as measured by CRP and related markers.

Diet quality. Mediterranean dietary patterns are consistently associated with lower CRP. The key elements: high intake of vegetables, fruits, legumes, whole grains, nuts, olive oil, and oily fish. Moderate intake of dairy and poultry. Low intake of red meat, processed meat, refined carbohydrates, and sugar. Anti-inflammatory effects likely come from the combination of omega-3 fatty acids, polyphenols, fibre, and micronutrients, not any single food.

Physical activity. Regular moderate exercise reduces CRP, typically by 20 to 30% in intervention studies. The mechanism involves reduction of visceral fat, improvement of insulin sensitivity, and direct anti-inflammatory effects of myokines (proteins released by exercising muscle). Both aerobic and resistance exercise are effective. Overtraining, conversely, can increase CRP.

Weight management. Weight loss, particularly loss of visceral fat, is one of the most powerful anti-inflammatory interventions available. Even modest weight loss (5 to 10% of body weight) significantly reduces CRP and inflammatory cytokines.

Sleep. Adequate sleep (7 to 9 hours, consistent timing) normalises inflammatory markers. Sleep improvement is one of the fastest-acting anti-inflammatory interventions. CRP can drop measurably within weeks of improved sleep.

Stress management. Chronic stress reduction through evidence-based practices (mindfulness, cognitive behavioural therapy, social connection, nature exposure, work-life boundaries) reduces cortisol-driven inflammation. The effect size is smaller than diet and exercise but clinically meaningful.

Alcohol reduction. Chronic alcohol consumption elevates CRP and inflammatory cytokines through liver stress, gut permeability, and direct immunological effects. Reducing or eliminating alcohol reduces inflammation.

Smoking cessation. Smoking is a potent pro-inflammatory exposure. CRP drops substantially within months of quitting.

What about anti-inflammatory supplements? Omega-3 (fish oil or algal DHA/EPA) has moderate evidence for reducing CRP in some populations. Curcumin has some evidence in specific inflammatory conditions. Most other "anti-inflammatory supplements" have weak or insufficient evidence. Lifestyle factors are first-line. Supplements are adjunctive at best.

How the test works

Standard blood test. Serum CRP or hs-CRP from a venous blood draw.

Fasting: Not strictly required for CRP alone, but reasonable if part of a broader fasting panel.

Timing: No significant circadian variation for CRP. Morning testing is standard for consistency.

Avoid testing when acutely unwell

Other considerations: Oral contraceptives and HRT can mildly elevate CRP. NSAIDs and statins can lower CRP. Obesity itself elevates baseline CRP.

Understanding your result

hs-CRP (cardiovascular and metabolic risk context)

Below 1.0 mg/L: Lower cardiovascular risk. Suggests minimal chronic inflammation.

1.0 to 3.0 mg/L: Moderate cardiovascular risk. May reflect early metabolic inflammation.

Above 3.0 mg/L (without acute illness): Higher cardiovascular risk. Warrants investigation of the inflammatory source and aggressive risk factor management.

Above 10.0 mg/L: Suggests acute inflammation (infection, injury, autoimmune flare). Not interpretable as a cardiovascular risk marker at this level. Identify and treat the acute cause, then retest when resolved.

Standard CRP

Below 5 mg/L: Generally considered normal.

5 to 10 mg/L: Mild elevation. May reflect low-grade infection, mild autoimmune activity, or metabolic inflammation.

10 to 100 mg/L: Moderate elevation. Active infection, autoimmune flare, significant tissue injury.

Above 100 mg/L: Severe elevation. Typically bacterial infection, sepsis, major tissue damage, or severe autoimmune flare. Requires urgent clinical attention.

Trending is more informative than single readings. My trajectory, 2.1 to 0.8 to 0.6, tells a story of improving metabolic health. A single reading of 1.5 doesn't tell you whether you're improving, stable, or declining. Test periodically and track.

Who should be testing

Tests to consider through Bloody Good

What to do after testing

If hs-CRP is below 1.0 mg/L: Lower inflammatory risk. Continue the lifestyle factors that got you here. Retest annually as part of routine monitoring.

If hs-CRP is 1.0 to 3.0 mg/L: Moderate zone. Review lifestyle factors: diet quality, exercise, sleep, alcohol, stress, weight. Investigate metabolic markers (HbA1c, fasting insulin, lipids) if not already done. This is the zone where lifestyle intervention has the highest impact-to-effort ratio. Retest in 6 months after making changes.

If hs-CRP is above 3.0 mg/L (without acute illness): Investigate the source. Is it metabolic (obesity, insulin resistance, NAFLD)? Is it autoimmune? Is it gut-related? Is it chronic infection? Your GP should integrate CRP with your full clinical picture and determine the appropriate investigation pathway.

If CRP is above 10 mg/L: This is acute inflammation territory. Are you unwell? Have you had a recent infection, injury, or procedure? If so, the elevation is expected and will resolve. If not, this warrants prompt GP assessment to identify the source.

Track over time. Inflammation is a trajectory, not a snapshot. Annual hs-CRP measurement, alongside your metabolic and cardiovascular markers, builds a picture of whether your body's inflammatory state is improving, stable, or worsening.

Explore more biomarkers

Browse the Bloody Good Biomarker Directory